StockClub

AURX

AURXNuo Therapeutics, Inc.$ --
Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.

AURX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
1M USD
YoY +168.8%
Operating Income
-0M USD
YoY +40.1%
Net Income
-1M USD
YoY +17.1%
EPS
-0.01$
YoY +19.5%

Revenue

$1.3M
FY2024 Q2$599,350
$599,350
Q2
FY2024 Q3$970,301
$970,301
Q3
FY2024 Q4$1.4M
$1.4M
Q4
FY2025 Q1$484,381
$484,381
Q1
FY2025 Q2$1.2M
$1.2M
Q2
FY2025 Q3$2.2M
$2.2M
Q3
FY2025 Q4$3.3M
$3.3M
Q4
FY2026 Q1$1.3M
$1.3M
Q1
Actual
+$817,734 (+168.8%)

Net Income

$-618,466
FY2024 Q2$-1.2M
$-1.2M
Q2
FY2024 Q3$-1.8M
$-1.8M
Q3
FY2024 Q4$-2.3M
$-2.3M
Q4
FY2025 Q1$-746,128
$-746,128
Q1
FY2025 Q2$-1.4M
$-1.4M
Q2
FY2025 Q3$-1.9M
$-1.9M
Q3
FY2025 Q4$-2.5M
$-2.5M
Q4
FY2026 Q1$-618,466
$-618,466
Q1
Actual
+$127,662 (+17.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$112,250
FY2022
$112,250
FY2023
Actual:$608,525
FY2023
$608,525
FY2024
Actual:$1.4M
FY2024
$1.4M
FY2025BEAT
Actual:$3.3M
Est:$3.1M
FY2025BEAT
$3.3M

Analyst Estimates

No forecast data